查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2135096

MHC複合體市場：全球市場預測，2026-2032年

MHC Complexes Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，MHC 複合物市場將成長至 2.8945 億美元，複合年成長率為 7.14%。

主要市場統計數據
基準年 2025 1.7856億美元
預計年份：2026年 1.9654億美元
預測年份 2032 2.8945億美元
複合年成長率 (%) 7.14%

MHC綜合體：執行摘要與策略背景

MHC複合物在抗原呈現、免疫辨識、移植生物學、感染疾病研究和腫瘤免疫學中發揮核心作用。此領域涵蓋天然存在的複合物、重組試劑、胜肽-MHC分析、結構表徵以及將分子識別與治療開發聯繫起來的研究流程。免疫學、基因組學、蛋白質組學、結構生物學和轉化醫學的進步推動了該領域的發展。

從單一試劑到整合免疫測定平台

該領域的發展趨勢正從單一的MHC試劑轉向整合胜肽發現、結合評估、結構分析、細胞層級檢驗和計算解釋的綜合平台。檢測方法的標準化、對偶基因特異性結合表徵的改進以及對可重複性的日益重視正成為關鍵的差異化因素。同時，對支持疾病監測、疫苗研發、免疫分析和精準治療設計的工具的需求也不斷成長。

人工智慧加速胜肽-MHC分析

人工智慧日益廣泛地應用於肽鍵預測、抗原優先排序、免疫抗原性評估、結構建模以及免疫肽體學資料集分析。其最大的貢獻在於幫助研究人員縮小實驗選擇範圍並整合異質性生物學數據。然而，模型的性能仍然依賴具有代表性的訓練數據、針對不同MHC等位基因和人群的嚴格檢驗、透明的評估以及實驗驗證，而不僅僅是計算排名。

區域洞察：多元化的研究能力與轉化研究重點

在北美，先進的生物醫學研究基礎設施與免疫腫瘤學、移植和生物技術領域的積極參與相融合。在歐洲，合作、監管品質和人口多樣性備受重視。同時，亞太地區不斷擴展的生命科學能力，以及對感染疾病、基因組學和精準醫學的濃厚興趣，是其優勢所在。拉丁美洲正在加強轉化醫學和學術研究能力，其重點研究領域通常與感染疾病和特定族群的免疫變異有關。在中東，研究和臨床基礎設施正在發展，尤其是在國家層級的協調努力下。在非洲，區域​​性免疫學、病原體研究和能力建構方面存在著巨大的機遇，但在取得專業設備和生物資訊資源的差距仍然存在。

團體洞察：夥伴關係塑造標準、存取與協作

東南亞國協在努力解決基礎設施、監管體系和人群遺傳學的差異的同時，也不斷擴大科學合作。金磚國家成員國為研究多樣性做出了顯著貢獻，並日益重視國內生物醫學能力建設，儘管資源取得和協調方面仍存在不足。歐盟受益於跨境研究框架和共用的科學優先事項。七國集團成員國在先進免疫學、資料科學和轉化醫學發展方面擁有強大的實力。海灣合作理事會成員國正在投資醫療衛生現代化、研究基礎設施和精準醫療。北約成員國支持廣泛的生物醫學網路和以備戰為重點的研究，其合作受到國家政策、安全考量和倫理管治。

國家洞察：重點國內市場的獨特優勢

美國和加拿大在免疫學、生物技術、臨床研究和計算生物學領域擁有強大的實力。英國、法國、德國、義大利和西班牙整合了大學、醫院和公共研究機構的優勢，特別注重轉化科學和合作研究基礎設施。中國、日本、韓國、印度和澳洲正在推動基因組學、蛋白質組學、生物醫學工程和精準醫療等應用領域的發展，儘管它們各自的研究生態系統在規模和專業化程度上有所不同。巴西、墨西哥和俄羅斯在感染疾病、人群特異性等位基因和國內研究能力方面擁有豐富的學術和臨床經驗。

給領導者的建議：建立可複製的工作流程，並考慮群體特徵。

產業領導者應優先考慮可互通的工作流程，將試劑品管、胜肽段鑑定、結合實驗、結構證據和細胞層級檢驗連接起來。他們還應擴大等位基因和人群覆蓋範圍，揭示模型學習的局限性，並利用外部檢驗來增強對計算結果的信心。與醫院、學術實驗室、生物樣本庫和公共衛生組織的合作可以加速具有臨床意義的應用。投資還應關注數據管治、標準化報告、專業人員配備和區域可及性，以確保先進的MHC複合物研究可靠且廣泛可及。

調查方法：基於證據整合MHC複合物的現狀

本執行摘要相容性複合體（MHC）複合物相關的既有科學和轉化研究課題進行了結構化的定性回顧。評估系統地整合了抗原呈現、胜肽-MHC生物學、免疫胜肽體學、結構分析技術、人工智慧、區域研究能力和合作研究團隊等領域的證據。結論從已證實的能力、研究重點和技術方向三個層面來闡述。本概要不包含任何市場估算、預測、市場佔有率資料或針對特定公司的聲明。

結論：整合和檢驗將決定下一步措施。

對主要組織相容性複合體（MHC）複合物的研究正變得日益整合、數據密集，並與轉化醫學緊密相連。持續進展將得益於計算優先排序與嚴格的實驗檢驗相結合、提高不同等位基因和人群的代表性，以及加強跨地區和跨機構的合作。那些優先考慮可重複性、互通性、符合倫理的數據使用以及具有臨床意義的檢驗的領導者，將更有能力把免疫認知科學的進展轉化為可操作的研究和醫療保健應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 MHC 複合物市場：依產品類型分類

  • 右旋糖酐
    • 一級右旋糖酐
    • 二級右旋
  • 單體
    • 第一類單體
    • 第二類單體
  • 五星
    • I類五聚體
    • II 類五聚體
  • 四聚體
    • I類四聚體
    • Ⅱ類四聚體

第8章 MHC 複合物市場：依技術分類

  • ELISA
  • 流式細胞技術
  • 質譜分析
  • 表面等離子體共振

第9章 MHC 複合物市場：按應用分類

  • 細胞分選
    • FACS
    • Macs
  • 疾病診斷
  • 流式細胞技術
  • 免疫測量
    • ELISA
    • 質譜分析
  • 疫苗研發

第10章：MHC 複合體市場：依最終用戶分類

  • 學術研究機構
  • 受託研究機構
  • 診斷檢查室
  • 製藥和生物技術公司
    • 大型製藥企業
    • 小規模生技公司

第11章：MHC綜合市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章 MHC 複合市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：MHC綜合市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Abcam plc
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Danaher Corporation
  • Merck KGaA
  • PerkinElmer, Inc.
  • Qiagen NV
  • Thermo Fisher Scientific Inc.

第16章 主要專家

Product Code: MRR-961F26FD62B3

The MHC Complexes Market is projected to grow by USD 289.45 million at a CAGR of 7.14% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 178.56 million
Estimated Year [2026] USD 196.54 million
Forecast Year [2032] USD 289.45 million
CAGR (%) 7.14%

MHC Complexes: Executive Summary and Strategic Context

MHC complexes are central to antigen presentation, immune recognition, transplantation biology, infectious-disease research, and immuno-oncology. The field spans naturally occurring complexes, recombinant reagents, peptide-MHC analysis, structural characterization, and research workflows that connect molecular recognition with therapeutic development. Progress is shaped by advances in immunology, genomics, proteomics, structural biology, and translational medicine.

From Static Reagents to Integrated Immune-Recognition Platforms

The landscape is shifting from isolated MHC reagents toward integrated platforms that combine peptide discovery, binding assessment, structural analysis, cellular validation, and computational interpretation. Standardization of assays, improved characterization of allele-specific binding, and greater attention to reproducibility are becoming important differentiators. At the same time, demand is expanding for tools that support disease monitoring, vaccine research, immune profiling, and precision therapeutic design.

Artificial Intelligence Accelerates Peptide-MHC Interpretation

Artificial intelligence is increasingly applied to peptide-binding prediction, antigen prioritization, immunogenicity assessment, structure modeling, and analysis of immunopeptidomics datasets. Its strongest contribution is helping researchers narrow experimental choices and integrate heterogeneous biological data. However, model performance remains dependent on representative training data, careful validation across MHC alleles and populations, transparent evaluation, and experimental confirmation rather than computational ranking alone.

Regional Insights: Diverse Research Capacity and Translational Priorities

North America combines advanced biomedical research infrastructure with strong activity in immuno-oncology, transplantation, and biotechnology. Europe emphasizes collaborative research, regulatory quality, and population diversity, while Asia-Pacific benefits from expanding life-science capabilities and significant interest in infectious disease, genomics, and precision medicine. Latin America is strengthening translational and academic capacity, with priorities often linked to infectious diseases and population-specific immune variation. The Middle East is developing research and clinical infrastructure, particularly through coordinated national initiatives. Africa presents important opportunities for locally relevant immunology, pathogen research, and capacity building, while continuing to face uneven access to specialized instrumentation and bioinformatics.

Group Insights: Alliances Shape Standards, Access, and Collaboration

ASEAN countries are increasing scientific collaboration while addressing differences in infrastructure, regulatory systems, and population genetics. BRICS members contribute substantial research diversity and increasingly emphasize domestic biomedical capability, although access and coordination remain uneven. The European Union benefits from cross-border research frameworks and shared scientific priorities. G7 members retain strong capabilities in advanced immunology, data science, and translational development. GCC countries are investing in healthcare modernization, research infrastructure, and precision medicine. NATO members support extensive biomedical networks and preparedness-oriented research, with collaboration shaped by national policy, security considerations, and ethical governance.

Country Insights: Distinct Capabilities Across Priority National Markets

The United States and Canada have established strengths in immunology, biotechnology, clinical research, and computational biology. The United Kingdom, France, Germany, Italy, and Spain combine university, hospital, and public-research capabilities, with particular emphasis on translational science and collaborative infrastructure. China, Japan, South Korea, India, and Australia are advancing genomics, proteomics, biomedical engineering, and precision-health applications, while their research ecosystems differ in scale and specialization. Brazil, Mexico, and Russia contribute important academic and clinical expertise, with opportunities tied to infectious disease, population-specific alleles, and domestic research capacity.

Recommendations for Leaders: Build Reproducible, Population-Aware Workflows

Industry leaders should prioritize interoperable workflows that connect reagent quality control, peptide identification, binding assays, structural evidence, and cellular validation. They should expand allele and population coverage, disclose model-training limitations, and use external validation to improve confidence in computational outputs. Partnerships with hospitals, academic laboratories, biobanks, and public-health organizations can accelerate clinically relevant applications. Investment should also address data governance, standardized reporting, skilled personnel, and regional access so that advanced MHC-complex research is both reliable and broadly usable.

Research Methodology: Evidence-Based Synthesis of the MHC-Complexes Landscape

This executive summary uses a structured qualitative review of established scientific and translational themes associated with MHC complexes. The assessment organizes evidence across antigen presentation, peptide-MHC biology, immunopeptidomics, structural methods, artificial intelligence, regional research capacity, and collaborative groupings. Claims are framed at the level of documented capabilities, research priorities, and technology directions. No market estimates, shares, forecasts, or company-specific claims are used.

Conclusion: Integration and Validation Will Define the Next Phase

MHC-complex research is becoming more integrated, data-intensive, and closely connected to translational medicine. The most durable progress will come from combining computational prioritization with rigorous experimental validation, improving representation of diverse alleles and populations, and strengthening collaboration across regions and institutions. Leaders that emphasize reproducibility, interoperability, ethical data use, and clinically relevant validation will be best positioned to convert advances in immune-recognition science into practical research and healthcare applications.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. MHC Complexes Market, by Product Type

  • 7.1. Introduction
  • 7.2. Dextramers
    • 7.2.1. Class I Dextramers
    • 7.2.2. Class II Dextramers
  • 7.3. Monomers
    • 7.3.1. Class I Monomers
    • 7.3.2. Class II Monomers
  • 7.4. Pentamers
    • 7.4.1. Class I Pentamers
    • 7.4.2. Class II Pentamers
  • 7.5. Tetramers
    • 7.5.1. Class I Tetramers
    • 7.5.2. Class II Tetramers

8. MHC Complexes Market, by Technology

  • 8.1. Introduction
  • 8.2. Elisa
  • 8.3. Flow Cytometry
  • 8.4. Mass Spectrometry
  • 8.5. Surface Plasmon Resonance

9. MHC Complexes Market, by Application

  • 9.1. Introduction
  • 9.2. Cell Sorting
    • 9.2.1. Facs
    • 9.2.2. Macs
  • 9.3. Disease Diagnostics
  • 9.4. Flow Cytometry
  • 9.5. Immunoassays
    • 9.5.1. Elisa
    • 9.5.2. Mass Spectrometry
  • 9.6. Vaccine Development

10. MHC Complexes Market, by End User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Diagnostic Laboratories
  • 10.5. Pharmaceutical & Biotechnology Companies
    • 10.5.1. Large Pharma
    • 10.5.2. Small Biotech

11. MHC Complexes Market, by Region

  • 11.1. Introduction
  • 11.2. Asia-Pacific
  • 11.3. North America
  • 11.4. Latin America
  • 11.5. Europe
  • 11.6. Middle East
  • 11.7. Africa

12. MHC Complexes Market, by Group

  • 12.1. Introduction
  • 12.2. ASEAN
  • 12.3. GCC
  • 12.4. European Union
  • 12.5. BRICS
  • 12.6. G7
  • 12.7. NATO

13. MHC Complexes Market, by Country

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. United Kingdom
  • 13.7. Germany
  • 13.8. France
  • 13.9. Russia
  • 13.10. Italy
  • 13.11. Spain
  • 13.12. China
  • 13.13. India
  • 13.14. Japan
  • 13.15. Australia
  • 13.16. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. Market Concentration Analysis, 2025
    • 14.2.1. Concentration Ratio (CR)
    • 14.2.2. Herfindahl Hirschman Index (HHI)
  • 14.3. Recent Developments & Impact Analysis, 2025
  • 14.4. Product Portfolio Analysis, 2025
  • 14.5. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Abcam plc
  • 15.2. Agilent Technologies, Inc.
  • 15.3. Becton, Dickinson and Company
  • 15.4. Bio-Rad Laboratories, Inc.
  • 15.5. Bio-Techne Corporation
  • 15.6. Danaher Corporation
  • 15.7. Merck KGaA
  • 15.8. PerkinElmer, Inc.
  • 15.9. Qiagen N.V.
  • 15.10. Thermo Fisher Scientific Inc.

16. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global MHC Complexes Market, Years Considered for the Study
  • FIGURE 2. Global MHC Complexes Market, Research Design
  • FIGURE 3. Global MHC Complexes Market, Research Framework
  • FIGURE 4. Global MHC Complexes Market, Data Triangulation
  • FIGURE 5. Global MHC Complexes Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global MHC Complexes Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global MHC Complexes Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global MHC Complexes Market Size, by Technology, 2025 vs 2032 (%)
  • FIGURE 9. Global MHC Complexes Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global MHC Complexes Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 11. Global MHC Complexes Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global MHC Complexes Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 13. Global MHC Complexes Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global MHC Complexes Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 15. Global MHC Complexes Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global MHC Complexes Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 17. Global MHC Complexes Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 18. Global MHC Complexes Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global MHC Complexes Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global MHC Complexes Market Segmentation & Coverage
  • TABLE 2. Global MHC Complexes Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Dextramers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Dextramers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Dextramers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Class I Dextramers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Class I Dextramers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Class I Dextramers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Class II Dextramers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Class II Dextramers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Class II Dextramers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Monomers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Monomers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Monomers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Class I Monomers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Class I Monomers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Class I Monomers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Class II Monomers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Class II Monomers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Class II Monomers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Pentamers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Pentamers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Pentamers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Class I Pentamers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Class I Pentamers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Class I Pentamers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Class II Pentamers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Class II Pentamers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Class II Pentamers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Tetramers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Tetramers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Tetramers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Class I Tetramers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Class I Tetramers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Class I Tetramers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Class II Tetramers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Class II Tetramers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Class II Tetramers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 41. Global Elisa Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 42. Global Elisa Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 43. Global Elisa Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 44. Global Flow Cytometry Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 45. Global Flow Cytometry Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 46. Global Flow Cytometry Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 47. Global Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 48. Global Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 49. Global Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 50. Global Surface Plasmon Resonance Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 51. Global Surface Plasmon Resonance Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 52. Global Surface Plasmon Resonance Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 53. Global MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 54. Global Cell Sorting Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 55. Global Cell Sorting Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 56. Global Cell Sorting Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 57. Global Facs Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 58. Global Facs Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 59. Global Facs Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 60. Global Macs Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 61. Global Macs Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 62. Global Macs Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 63. Global Disease Diagnostics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 64. Global Disease Diagnostics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 65. Global Disease Diagnostics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 66. Global Flow Cytometry Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 67. Global Flow Cytometry Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 68. Global Flow Cytometry Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 69. Global Immunoassays Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. Global Immunoassays Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 71. Global Immunoassays Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 72. Global Elisa Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 73. Global Elisa Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 74. Global Elisa Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 75. Global Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 76. Global Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 77. Global Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 78. Global Vaccine Development Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 79. Global Vaccine Development Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 80. Global Vaccine Development Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 81. Global MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 82. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 83. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 84. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 85. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 86. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 87. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 88. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 89. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 90. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 91. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 92. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 93. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 94. Global Large Pharma Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 95. Global Large Pharma Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 96. Global Large Pharma Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 97. Global Small Biotech Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 98. Global Small Biotech Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 99. Global Small Biotech Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 100. Global MHC Complexes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 101. Asia-Pacific MHC Complexes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 102. Asia-Pacific MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 103. Asia-Pacific MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 104. Asia-Pacific MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 105. Asia-Pacific MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 106. Asia-Pacific MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 107. Asia-Pacific MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 108. Asia-Pacific MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 109. Asia-Pacific MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 110. Asia-Pacific MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 111. Asia-Pacific MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 112. Asia-Pacific MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 113. North America MHC Complexes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 114. North America MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 115. North America MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 116. North America MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 117. North America MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 118. North America MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 119. North America MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 120. North America MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 121. North America MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 122. North America MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 123. North America MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 124. North America MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 125. Latin America MHC Complexes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 126. Latin America MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 127. Latin America MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 128. Latin America MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 129. Latin America MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 130. Latin America MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 131. Latin America MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 132. Latin America MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 133. Latin America MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 134. Latin America MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 135. Latin America MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 136. Latin America MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 137. Europe MHC Complexes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 138. Europe MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 139. Europe MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 140. Europe MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 141. Europe MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 142. Europe MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 143. Europe MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 144. Europe MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 145. Europe MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 146. Europe MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 147. Europe MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 148. Europe MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 149. Middle East MHC Complexes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 150. Middle East MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 151. Middle East MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 152. Middle East MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 153. Middle East MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 154. Middle East MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 155. Middle East MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 156. Middle East MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 157. Middle East MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 158. Middle East MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 159. Middle East MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 160. Middle East MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 161. Africa MHC Complexes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 162. Africa MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 163. Africa MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 164. Africa MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 165. Africa MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 166. Africa MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 167. Africa MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 168. Africa MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 169. Africa MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 170. Africa MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 171. Africa MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 172. Africa MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 173. Global MHC Complexes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 174. ASEAN MHC Complexes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 175. ASEAN MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 176. ASEAN MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 177. ASEAN MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 178. ASEAN MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 179. ASEAN MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 180. ASEAN MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 181. ASEAN MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 182. ASEAN MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 183. ASEAN MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 184. ASEAN MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 185. ASEAN MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 186. GCC MHC Complexes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 187. GCC MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 188. GCC MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 189. GCC MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 190. GCC MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 191. GCC MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 192. GCC MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 193. GCC MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 194. GCC MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 195. GCC MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 196. GCC MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 197. GCC MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 198. European Union MHC Complexes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 199. European Union MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 200. European Union MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 201. European Union MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 202. European Union MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 203. European Union MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 204. European Union MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 205. European Union MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 206. European Union MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 207. European Union MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 208. European Union MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 209. European Union MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 210. BRICS MHC Complexes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 211. BRICS MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 212. BRICS MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 213. BRICS MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 214. BRICS MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 215. BRICS MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 216. BRICS MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 217. BRICS MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 218. BRICS MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 219. BRICS MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 220. BRICS MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 221. BRICS MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 222. G7 MHC Complexes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 223. G7 MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 224. G7 MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 225. G7 MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 226. G7 MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 227. G7 MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 228. G7 MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 229. G7 MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 230. G7 MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 231. G7 MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 232. G7 MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 233. G7 MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 234. NATO MHC Complexes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 235. NATO MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 236. NATO MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 237. NATO MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 238. NATO MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 239. NATO MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 240. NATO MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 241. NATO MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 242. NATO MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 243. NATO MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 244. NATO MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 245. NATO MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 246. Global MHC Complexes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 247. United States MHC Complexes Market Size, 2017-2032 (USD Million)
  • TABLE 248. United States MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 249. United States MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 250. United States MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 251. United States MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 252. United States MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 253. United States MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 254. United States MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 255. United States MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 256. United States MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 257. United States MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 258. United States MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 259. Canada MHC Complexes Market Size, 2017-2032 (USD Million)
  • TABLE 260. Canada MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 261. Canada MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 262. Canada MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 263. Canada MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 264. Canada MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 265. Canada MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 266. Canada MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 267. Canada MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 268. Canada MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 269. Canada MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 270. Canada MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 271. Mexico MHC Complexes Market Size, 2017-2032 (USD Million)
  • TABLE 272. Mexico MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 273. Mexico MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 274. Mexico MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 275. Mexico MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 276. Mexico MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 277. Mexico MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 278. Mexico MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 279. Mexico MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 280. Mexico MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 281. Mexico MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 282. Mexico MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 283. Brazil MHC Complexes Market Size, 2017-2032 (USD Million)
  • TABLE 284. Brazil MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 285. Brazil MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 286. Brazil MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 287. Brazil MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 288. Brazil MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 289. Brazil MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 290. Brazil MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 291. Brazil MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 292. Brazil MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 293. Brazil MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 294. Brazil MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 295. United Kingdom MHC Complexes Market Size, 2017-2032 (USD Million)
  • TABLE 296. United Kingdom MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 297. United Kingdom MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 298. United Kingdom MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 299. United Kingdom MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 300. United Kingdom MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 301. United Kingdom MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 302. United Kingdom MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 303. United Kingdom MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 304. United Kingdom MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 305. United Kingdom MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 306. United Kingdom MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 307. Germany MHC Complexes Market Size, 2017-2032 (USD Million)
  • TABLE 308. Germany MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 309. Germany MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 310. Germany MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 311. Germany MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 312. Germany MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 313. Germany MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 314. Germany MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 315. Germany MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 316. Germany MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 317. Germany MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 318. Germany MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 319. France MHC Complexes Market Size, 2017-2032 (USD Million)
  • TABLE 320. France MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 321. France MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 322. France MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 323. France MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 324. France MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 325. France MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 326. France MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 327. France MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 328. France MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 329. France MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 330. France MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 331. Russia MHC Complexes Market Size, 2017-2032 (USD Million)
  • TABLE 332. Russia MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 333. Russia MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 334. Russia MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 335. Russia MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 336. Russia MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 337. Russia MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 338. Russia MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 339. Russia MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 340. Russia MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 341. Russia MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 342. Russia MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 343. Italy MHC Complexes Market Size, 2017-2032 (USD Million)
  • TABLE 344. Italy MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 345. Italy MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 346. Italy MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 347. Italy MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 348. Italy MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 349. Italy MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 350. Italy MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 351. Italy MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 352. Italy MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 353. Italy MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 354. Italy MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 355. Spain MHC Complexes Market Size, 2017-2032 (USD Million)
  • TABLE 356. Spain MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 357. Spain MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 358. Spain MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 359. Spain MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 360. Spain MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 361. Spain MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 362. Spain MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 363. Spain MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 364. Spain MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 365. Spain MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 366. Spain MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 367. China MHC Complexes Market Size, 2017-2032 (USD Million)
  • TABLE 368. China MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 369. China MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 370. China MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 371. China MHC Complexes Market Size, by Pentamers, 2017-2032 (USD Million)
  • TABLE 372. China MHC Complexes Market Size, by Tetramers, 2017-2032 (USD Million)
  • TABLE 373. China MHC Complexes Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 374. China MHC Complexes Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 375. China MHC Complexes Market Size, by Cell Sorting, 2017-2032 (USD Million)
  • TABLE 376. China MHC Complexes Market Size, by Immunoassays, 2017-2032 (USD Million)
  • TABLE 377. China MHC Complexes Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 378. China MHC Complexes Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 379. India MHC Complexes Market Size, 2017-2032 (USD Million)
  • TABLE 380. India MHC Complexes Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 381. India MHC Complexes Market Size, by Dextramers, 2017-2032 (USD Million)
  • TABLE 382. India MHC Complexes Market Size, by Monomers, 2017-2032 (USD Million)
  • TABLE 383. India MHC Complexes Market Size